z-logo
open-access-imgOpen Access
Clinical efficacy of plasma exchange in patients with autoimmune encephalitis
Author(s) -
Zhang Yan,
Huang Huijin,
Chen Weibi,
Liu Gang,
Liu Fang,
Su Yingying
Publication year - 2021
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.51313
Subject(s) - medicine , autoimmune encephalitis , encephalitis , refractory (planetary science) , adverse effect , antibody , gastroenterology , surgery , immunology , virus , physics , astrobiology
Objective To determine the clinical and antibody response after therapeutic plasma exchange (TPE) in patients with severe refractory antibody‐associated autoimmune encephalitis (AE). Methods This single‐center prospective cohort included all patients consecutively admitted to our hospital because of severe refractory AE over the period from July 2014 to June 2019. All patients received immunotherapy (steroids, intravenous immunoglobulin (IVIG), and/or TPE). The primary outcome was evaluated at 1‐ and 2‐month postenrollment, and the long‐term outcome was followed up at 6 and 12 months. AE antibody titers in the cerebrospinal fluid and plasma were evaluated before and after TPE/IVIG. Results This study enrolled 57 patients with severe refractory AE, including anti‐NMDA receptor encephalitis ( n  = 51), anti‐GABAb receptor encephalitis ( n  = 3), anti‐LGI 1 encephalitis ( n  = 2), and anti‐AMPA receptor encephalitis ( n  = 1). Of all 57 patients, 33 patients received TPE for a total of 193 procedures, and 24 patients with contraindications or refusal of TPE were in the non‐TPE group. Compared with the non‐TPE group, the TPE group exhibited greater clinical improvement: 21 (37%) versus 8 (14%) after 1 month ( P  = 0.03) and 31 (54%) versus 16 (28%) after 2 months ( P  = 0.01), respectively. Complications and adverse events associated with TPE occurred in 91 procedures (47%) without serious adverse events associated with the use of TPE. Interpretation TPE might be an effective rescue therapy associated with rapid functional improvement in patients with severe steroid/IVIG refractory antibody‐associated AE from this nonrandomized control trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here